Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
- PMID: 11279122
- DOI: 10.1074/jbc.M100710200
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
Abstract
We have created early-onset transgenic (Tg) models by exploiting the synergistic effects of familial Alzheimer's disease mutations on amyloid beta-peptide (Abeta) biogenesis. TgCRND8 mice encode a double mutant form of amyloid precursor protein 695 (KM670/671NL+V717F) under the control of the PrP gene promoter. Thioflavine S-positive Abeta amyloid deposits are present at 3 months, with dense-cored plaques and neuritic pathology evident from 5 months of age. TgCRND8 mice exhibit 3,200-4,600 pmol of Abeta42 per g brain at age 6 months, with an excess of Abeta42 over Abeta40. High level production of the pathogenic Abeta42 form of Abeta peptide was associated with an early impairment in TgCRND8 mice in acquisition and learning reversal in the reference memory version of the Morris water maze, present by 3 months of age. Notably, learning impairment in young mice was offset by immunization against Abeta42 (Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., Mount, H. T. J., Nixon, R. A., Mercken, M., Bergeron, C., Fraser, P. E., St. George-Hyslop, P., and Westaway, D. (2000) Nature 408, 979-982). Amyloid deposition in TgCRND8 mice was enhanced by the expression of presenilin 1 transgenes including familial Alzheimer's disease mutations; for mice also expressing a M146L+L286V presenilin 1 transgene, amyloid deposits were apparent by 1 month of age. The Tg mice described here suggest a potential to investigate aspects of Alzheimer's disease pathogenesis, prophylaxis, and therapy within short time frames.
Similar articles
-
BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.Neurodegener Dis. 2005;2(6):284-98. doi: 10.1159/000092314. Neurodegener Dis. 2005. PMID: 16909011
-
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.Neurobiol Dis. 2005 Apr;18(3):602-17. doi: 10.1016/j.nbd.2004.10.022. Neurobiol Dis. 2005. PMID: 15755686
-
A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.J Alzheimers Dis. 2010;20(1):113-26. doi: 10.3233/JAD-2010-1349. J Alzheimers Dis. 2010. PMID: 20164597
-
Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.Curr Alzheimer Res. 2018;15(11):1053-1061. doi: 10.2174/1567205015666180709112327. Curr Alzheimer Res. 2018. PMID: 29984654
-
Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.Exp Gerontol. 2000 Sep;35(6-7):831-41. doi: 10.1016/s0531-5565(00)00149-2. Exp Gerontol. 2000. PMID: 11053674 Review.
Cited by
-
Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology.Br J Clin Pharmacol. 2017 Jan;83(1):54-62. doi: 10.1111/bcp.12993. Epub 2016 May 21. Br J Clin Pharmacol. 2017. PMID: 27131215 Free PMC article. Review.
-
Harnessing neurogenesis in the adult brain-A role in type 2 diabetes mellitus and Alzheimer's disease.Int Rev Neurobiol. 2020;155:235-269. doi: 10.1016/bs.irn.2020.03.020. Int Rev Neurobiol. 2020. PMID: 32854856 Free PMC article. Review.
-
Effect of Unloaded and Curcumin-Loaded Solid Lipid Nanoparticles on Tissue Transglutaminase Isoforms Expression Levels in an Experimental Model of Alzheimer's Disease.Antioxidants (Basel). 2022 Sep 21;11(10):1863. doi: 10.3390/antiox11101863. Antioxidants (Basel). 2022. PMID: 36290586 Free PMC article.
-
A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapies.Mol Ther Methods Clin Dev. 2023 Oct 31;31:101146. doi: 10.1016/j.omtm.2023.101146. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38027063 Free PMC article.
-
Ocular manifestations of Alzheimer's disease in animal models.Int J Alzheimers Dis. 2012;2012:786494. doi: 10.1155/2012/786494. Epub 2012 May 15. Int J Alzheimers Dis. 2012. PMID: 22666623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous